BRIGHT MINDS BIOSCIENCES INC. - DRUG

Ownership (Schedule 13D / 13G) · latest 50 filings · Back to all files
Visible: 0
Filed Form Reporting person Percent Shares SEC
May 15, 2026 SCHEDULE 13G Vestal Point Capital, LP 5.0% 492,319 View
May 15, 2026 SCHEDULE 13G Ryan Wilder 5.0% 492,319 View
May 15, 2026 SCHEDULE 13G/A JANUS HENDERSON GROUP PLC 13.1% 1,284,324 View
May 15, 2026 SCHEDULE 13G/A JANUS HENDERSON GROUP PLC 13.1% 1,284,324 View
May 12, 2026 SCHEDULE 13G/A Vivo Opportunity Fund Holdings, L.P. 5.2% 504,645 View
May 12, 2026 SCHEDULE 13G/A Vivo Opportunity, LLC 5.2% 504,645 View
May 12, 2026 SCHEDULE 13G/A Vivo Opportunity Cayman Fund, L.P. 0.5% 52,527 View
May 12, 2026 SCHEDULE 13G/A Vivo Opportunity Cayman, LLC 0.5% 52,527 View
Apr 30, 2026 SCHEDULE 13G/A Cormorant Asset Management, LP 9.71% 950,000 View
Apr 30, 2026 SCHEDULE 13G/A Chen Bihua 9.71% 950,000 View
Feb 17, 2026 SCHEDULE 13G/A JANUS HENDERSON GROUP PLC 14.9% 1,155,995 View
Feb 17, 2026 SCHEDULE 13G/A Commodore Capital LP 0.3% 18,851 View
Feb 17, 2026 SCHEDULE 13G/A Commodore Capital Master LP 0.3% 18,851 View
Feb 17, 2026 SCHEDULE 13G/A Perceptive Advisors LLC 4.6% 449,290 View
Feb 17, 2026 SCHEDULE 13G/A Joseph Edelman 4.6% 449,290 View
Feb 17, 2026 SCHEDULE 13G/A Perceptive Life Sciences Master Fund, Ltd. 4.6% 449,290 View
Feb 06, 2026 SCHEDULE 13G/A Cormorant Asset Management, LP 10.88% 1,059,331 View
Feb 06, 2026 SCHEDULE 13G/A Bihua Chen 10.88% 1,059,331 View
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G. Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F). Amendments (/A) can repeat the same holder over time, so rows should not be summed. Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.